.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Argus Health
Covington
Cipla
Fuji
Harvard Business School
Medtronic
Accenture
Baxter
Colorcon

Generated: February 18, 2018

DrugPatentWatch Database Preview

Patents Expiring in July 2024

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-005Oct 7, 2016RXYesNo➤ Try a Free Trial➤ Try a Free TrialUSE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-004Dec 20, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialUSE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-003Dec 20, 2013RXYesNo➤ Try a Free Trial➤ Try a Free TrialUSE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-002Dec 20, 2013RXYesNo➤ Try a Free Trial➤ Try a Free TrialUSE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-001Dec 20, 2013RXYesNo➤ Try a Free Trial➤ Try a Free TrialUSE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
OrexigenCONTRAVEbupropion hydrochloride; naltrexone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200063-001Sep 10, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialFOR EFFECT ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH INSULIN RESISTANCE
OrexigenCONTRAVEbupropion hydrochloride; naltrexone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200063-001Sep 10, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialFOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
Clovis Oncology IncRUBRACArucaparib camsylateTABLET;ORAL209115-003May 1, 2017RXYesNo➤ Try a Free Trial➤ Try a Free TrialA METHOD FOR TREATING OVARIAN CANCER BY ADMINISTERING RUCAPARIB, WHEREIN THE CANCER IS ASSOCIATED WITH A DELETERIOUS BRCA MUTATION
Clovis Oncology IncRUBRACArucaparib camsylateTABLET;ORAL209115-003May 1, 2017RXYesNo➤ Try a Free Trial➤ Try a Free TrialA METHOD FOR TREATING OVARIAN CANCER BY ADMINISTERING RUCAPARIB, WHEREIN THE CANCER IS ASSOCIATED WITH A DELETERIOUS BRCA MUTATION
Clovis Oncology IncRUBRACArucaparib camsylateTABLET;ORAL209115-001Dec 19, 2016RXYesNo➤ Try a Free Trial➤ Try a Free TrialA METHOD FOR TREATING OVARIAN CANCER BY ADMINISTERING RUCAPARIB, WHEREIN THE CANCER IS ASSOCIATED WITH A DELETERIOUS BRCA MUTATION
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Covington
Express Scripts
Cerilliant
McKinsey
QuintilesIMS
Chubb
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot